Header Logo

Connection

Philip Liebson to Coronary Disease

This is a "connection" page, showing publications Philip Liebson has written about Coronary Disease.
Connection Strength

0.565
  1. VALIANT and EUROPA. Prev Cardiol. 2004; 7(1):42-4.
    View in: PubMed
    Score: 0.220
  2. VISP and INVEST. Prev Cardiol. 2004; 7(2):93-6.
    View in: PubMed
    Score: 0.220
  3. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective. Cardiol Rev. 2004 Nov-Dec; 12(6):287-98.
    View in: PubMed
    Score: 0.058
  4. ALLHAT and AFFIRM. Prev Cardiol. 2003; 6(1):54-60.
    View in: PubMed
    Score: 0.051
  5. Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005 Jan; 45(1):58-63.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.